Apoptosis(凋亡)
As one of the cellular death mechanisms, apoptosis, also known as programmed cell death, can be defined as the process of a proper death of any cell under certain or necessary conditions. Apoptosis is controlled by the interactions between several molecules and responsible for the elimination of unwanted cells from the body.
Many biochemical events and a series of morphological changes occur at the early stage and increasingly continue till the end of apoptosis process. Morphological event cascade including cytoplasmic filament aggregation, nuclear condensation, cellular fragmentation, and plasma membrane blebbing finally results in the formation of apoptotic bodies. Several biochemical changes such as protein modifications/degradations, DNA and chromatin deteriorations, and synthesis of cell surface markers form morphological process during apoptosis.
Apoptosis can be stimulated by two different pathways: (1) intrinsic pathway (or mitochondria pathway) that mainly occurs via release of cytochrome c from the mitochondria and (2) extrinsic pathway when Fas death receptor is activated by a signal coming from the outside of the cell.
Different gene families such as caspases, inhibitor of apoptosis proteins, B cell lymphoma (Bcl)-2 family, tumor necrosis factor (TNF) receptor gene superfamily, or p53 gene are involved and/or collaborate in the process of apoptosis.
Caspase family comprises conserved cysteine aspartic-specific proteases, and members of caspase family are considerably crucial in the regulation of apoptosis. There are 14 different caspases in mammals, and they are basically classified as the initiators including caspase-2, -8, -9, and -10; and the effectors including caspase-3, -6, -7, and -14; and also the cytokine activators including caspase-1, -4, -5, -11, -12, and -13. In vertebrates, caspase-dependent apoptosis occurs through two main interconnected pathways which are intrinsic and extrinsic pathways. The intrinsic or mitochondrial apoptosis pathway can be activated through various cellular stresses that lead to cytochrome c release from the mitochondria and the formation of the apoptosome, comprised of APAF1, cytochrome c, ATP, and caspase-9, resulting in the activation of caspase-9. Active caspase-9 then initiates apoptosis by cleaving and thereby activating executioner caspases. The extrinsic apoptosis pathway is activated through the binding of a ligand to a death receptor, which in turn leads, with the help of the adapter proteins (FADD/TRADD), to recruitment, dimerization, and activation of caspase-8 (or 10). Active caspase-8 (or 10) then either initiates apoptosis directly by cleaving and thereby activating executioner caspase (-3, -6, -7), or activates the intrinsic apoptotic pathway through cleavage of BID to induce efficient cell death. In a heat shock-induced death, caspase-2 induces apoptosis via cleavage of Bid.
Bcl-2 family members are divided into three subfamilies including (i) pro-survival subfamily members (Bcl-2, Bcl-xl, Bcl-W, MCL1, and BFL1/A1), (ii) BH3-only subfamily members (Bad, Bim, Noxa, and Puma9), and (iii) pro-apoptotic mediator subfamily members (Bax and Bak). Following activation of the intrinsic pathway by cellular stress, pro‑apoptotic BCL‑2 homology 3 (BH3)‑only proteins inhibit the anti‑apoptotic proteins Bcl‑2, Bcl-xl, Bcl‑W and MCL1. The subsequent activation and oligomerization of the Bak and Bax result in mitochondrial outer membrane permeabilization (MOMP). This results in the release of cytochrome c and SMAC from the mitochondria. Cytochrome c forms a complex with caspase-9 and APAF1, which leads to the activation of caspase-9. Caspase-9 then activates caspase-3 and caspase-7, resulting in cell death. Inhibition of this process by anti‑apoptotic Bcl‑2 proteins occurs via sequestration of pro‑apoptotic proteins through binding to their BH3 motifs.
One of the most important ways of triggering apoptosis is mediated through death receptors (DRs), which are classified in TNF superfamily. There exist six DRs: DR1 (also called TNFR1); DR2 (also called Fas); DR3, to which VEGI binds; DR4 and DR5, to which TRAIL binds; and DR6, no ligand has yet been identified that binds to DR6. The induction of apoptosis by TNF ligands is initiated by binding to their specific DRs, such as TNFα/TNFR1, FasL /Fas (CD95, DR2), TRAIL (Apo2L)/DR4 (TRAIL-R1) or DR5 (TRAIL-R2). When TNF-α binds to TNFR1, it recruits a protein called TNFR-associated death domain (TRADD) through its death domain (DD). TRADD then recruits a protein called Fas-associated protein with death domain (FADD), which then sequentially activates caspase-8 and caspase-3, and thus apoptosis. Alternatively, TNF-α can activate mitochondria to sequentially release ROS, cytochrome c, and Bax, leading to activation of caspase-9 and caspase-3 and thus apoptosis. Some of the miRNAs can inhibit apoptosis by targeting the death-receptor pathway including miR-21, miR-24, and miR-200c.
p53 has the ability to activate intrinsic and extrinsic pathways of apoptosis by inducing transcription of several proteins like Puma, Bid, Bax, TRAIL-R2, and CD95.
Some inhibitors of apoptosis proteins (IAPs) can inhibit apoptosis indirectly (such as cIAP1/BIRC2, cIAP2/BIRC3) or inhibit caspase directly, such as XIAP/BIRC4 (inhibits caspase-3, -7, -9), and Bruce/BIRC6 (inhibits caspase-3, -6, -7, -8, -9).
Any alterations or abnormalities occurring in apoptotic processes contribute to development of human diseases and malignancies especially cancer.
References:
1.Yağmur Kiraz, Aysun Adan, Melis Kartal Yandim, et al. Major apoptotic mechanisms and genes involved in apoptosis[J]. Tumor Biology, 2016, 37(7):8471.
2.Aggarwal B B, Gupta S C, Kim J H. Historical perspectives on tumor necrosis factor and its superfamily: 25 years later, a golden journey.[J]. Blood, 2012, 119(3):651.
3.Ashkenazi A, Fairbrother W J, Leverson J D, et al. From basic apoptosis discoveries to advanced selective BCL-2 family inhibitors[J]. Nature Reviews Drug Discovery, 2017.
4.McIlwain D R, Berger T, Mak T W. Caspase functions in cell death and disease[J]. Cold Spring Harbor perspectives in biology, 2013, 5(4): a008656.
5.Ola M S, Nawaz M, Ahsan H. Role of Bcl-2 family proteins and caspases in the regulation of apoptosis[J]. Molecular and cellular biochemistry, 2011, 351(1-2): 41-58.
Products for Apoptosis
- Caspase(85)
- 14.3.3 Proteins(1)
- Apoptosis Inducers(43)
- Bax(7)
- Bcl-2 Family(106)
- Bcl-xL(8)
- c-RET(9)
- IAP(26)
- KEAP1-Nrf2(64)
- MDM2(12)
- p53(112)
- PC-PLC(4)
- PKD(8)
- RasGAP (Ras- P21)(1)
- Survivin(6)
- Thymidylate Synthase(10)
- TNF-α(128)
- Other Apoptosis(885)
- APC(5)
- PD-1/PD-L1 interaction(60)
- ASK1(3)
- PAR4(2)
- RIP kinase(50)
- FKBP(19)
- Pyroptosis(30)
- Cat.No. 产品名称 Information
-
GC37664
Sorafenib (D3)
索拉非尼-D3,Bay 43-9006-d3; Donafenib
An internal standard for the quantification of sorafenib - GC37649 SM-164 Hydrochloride A cell-permeable Smac mimetic
-
GC37646
SKF-86002
6-(4-氟苯基)-5-(4-吡啶基)-2,3-二氢咪唑并[2,1-B]-噻唑
An anti-inflammatory agent -
GC37633
SF1126
N2-[1,4-二氧代-4-[[4-(4-氧代-8-苯基-4H-1-苯并吡喃-2-基)吗啉-4-基]甲氧基]丁基]-L-精氨酰甘氨酰-L-ALPHA-天冬氨酰-L-丝氨酸内盐
SF1126 是临床相关的双重 PI3K/BRD4 泛抑制剂,具有抗肿瘤和抗血管生成活性。SF1126 是 RGDS-缀合的 LY294002 前药,其设计为表现出增加的溶解度并与肿瘤区室内的特定整联蛋白结合。SF1126 诱导细胞凋亡 (apoptosis)。 -
GC37555
Roquinimex
罗喹美克,Linomide; FCF89; ABR212616
An immunomodulator with diverse biological activities - GC37549 RO-5963 RO-5963 是 p53-MDM2 和 p53-MDMX 互相作用的双抑制剂,IC50 值分别约为 17 nM 和 24 nM。
-
GC37538
Ripretinib
瑞普替尼; DCC-2618
A KIT and PDGFRα inhibitor - GC37537 RIPK-IN-4 RIPK-IN-4 是一种有效选择性的、具有良好的口服生物利用度的 RIPK2 抑制剂,IC50 值为 3 nM。
- GC37536 RIPK1-IN-7 RIPK1-IN-7 is a potent and selective receptor-interacting serine/threonine-protein kinase 1 (RIPK1) inhibitor with a Kd of 4 nM and an enzymatic IC50 of 11 nM.
- GC37535 RIPK1-IN-3 RIPK1-IN-3 (Example 38) 是RIPK1 的抑制剂,信息来自专利WO2018148626A1,拥有抗炎活性。
- GC37533 RIP1 kinase inhibitor 1 RIP1 kinase inhibitor 1 (compound 22) 是一种高效的,口服有效的,可穿透大脑的 RIP1 激酶抑制剂 (pKi=9.04)。
-
GC37524
RGD peptide (GRGDNP) TFA
An inhibitor of integrin-
ligand interactions -
GC37038
Puerarin 6''-O-Xyloside
葛根素-6″-O-木糖苷
Puerarin 6''-O-Xyloside,是从葛根中分离得到的,拥有抗炎和抗癌活性。Puerarin 6''-O-Xyloside 可诱导线粒体介导的细胞凋亡通路。 - GC37035 PTC-028 A BMI1 inhibitor
- GC37013 PROTAC MDM2 Degrader-4 PROTAC MDM2 Degrader-4 是一种 PROTAC 类的 MDM2 降解剂。PROTAC MDM2 Degrader-4 由 MDM2 抑制剂,linker 和 E3 泛素连接酶 MDM2 配体组成。
- GC37012 PROTAC MDM2 Degrader-3 PROTAC MDM2 Degrader-3 是一种 PROTAC 类的 MDM2 降解剂。PROTAC MDM2 Degrader-3 由 MDM2 抑制剂,linker 和 E3 泛素连接酶 MDM2 配体组成。
- GC37011 PROTAC MDM2 Degrader-2 PROTAC MDM2 Degrader-2 是一种 PROTAC 类的 MDM2 降解剂。PROTAC MDM2 Degrader-2 由 MDM2 抑制剂,linker 和 E3 泛素连接酶 MDM2 配体组成。
- GC37010 PROTAC MDM2 Degrader-1 PROTAC MDM2 Degrader-1 是一种 PROTAC 类的 MDM2 降解剂。PROTAC MDM2 Degrader-1 由 MDM2 抑制剂,linker 和 E3 泛素连接酶 MDM2 配体组成。
- GC36933 PK68 PK68 is a potent orally active and specific inhibitor of receptor-interacting kinase 1 (RIPK1) with an IC50 of ~90?nM.
-
GC36930
Pitavastatin D4
NK-104 D4
Pitavastatin D4是Pitavastatin氘代化合物标准品。 -
GC36920
Pimpinellin
茴芹内酯
Pimpinellin 是 Cyrtomium fortumei (J.) 的一种成分。Pimpinellin 通过诱导肿瘤细胞凋亡 (apoptosis) 抑制肿瘤细胞的生长。 -
GC36904
Phytohemagglutinin
植物血凝素; PHA-M
Phytohemagglutinin (PHA, Phaseolus vulgaris agglutinin) is expressed in Pichia pastoris using native signal peptides, or the Saccharomyces alpha-factor preprosequence, to direct proteins into the secretory pathway. Phytohemagglutinin induces apoptosis in human HEp-2 carcinoma cells via increasing proapoptotic protein Bax and activating caspases-3. - GC36896 PhiKan 083 hydrochloride PhiKan 083 hydrochloride 是一种咔唑衍生物,可以稳定 p53 的突变体 Y220C,Kd 值为 167 μM,在 Ln229 细胞中,相对亲和力 (Kd) 为 150 μM;PhiKan 083 可用于癌症研究。
-
GC36895
Phenoxodiol
脱氢雌马酚,Idronoxil; Dehydroequol; Haginin E
A phenol with anticancer activity -
GC36892
PHA-767491 hydrochloride
1,5,6,7-四氢-2-(4-吡啶基)-4H-吡咯并[3,2-C]吡啶-4-酮盐酸盐,CAY-10572 hydrochloride
A potent Cdc7 kinase inhibitor -
GC36865
PEAQX tetrasodium hydrate
NVP-AAM077 tetrasodium hydrate
PEAQX (NVP-AAM077) is an effective and orally available human NMDA antagonist, which shows preference in excess of 100-fold for hNMDA 1A/2A (IC50=of 270 nM) over hNMDA 1A/2B receptors (IC50=29,600 nM). - GC36862 PD-1-IN-22 PD-1-IN-22 是一种有效的程序性细胞死亡 1 (PD-1)/程序性细胞死亡配体1 (PD-L1) 相互作用的抑制剂,IC50 为 92.3 nM。
-
GC36855
Paris saponin VII
重楼皂苷 VII; Chonglou Saponin VII
Chonglou Saponin VII (Dioscinin, Polyphyllin-VII, Paris saponin-VII), a kind of steroidal saponins from Chonglou (Rhizoma Paridis Chonglou), inhibits EMT and reduces the invasion of ovarian cancer cells via the GSK-3β/β-catenin signaling pathway. -
GC36848
Pantoprazole sodium hydrate
泮托拉唑钠水合物; BY1023 sodium hydrate; SKF96022 sodium hydrate
A proton pump inhibitor -
GC36847
Pantoprazole sodium
泮托拉唑钠; BY1023 sodium; SKF96022 sodium
A proton pump inhibitor -
GC36837
p53 and MDM2 proteins-interaction-inhibitor racemic
REL-2-[4-[[(4R,5S)-4,5-双(4-氯苯基)-2-[4-(1,1-二甲基乙基)-2-乙氧基苯基]-4,5-二氢-4,5-二甲基-1H-咪唑-1-基]羰基]-1-哌嗪基]-1-(4-吗啉基)乙酮
外消旋p53 and MDM2 proteins-interaction-inhibitor是p53与MDM2相互作用抑制剂。 - GC36836 p53 and MDM2 proteins-interaction-inhibitor dihydrochloride p53 and MDM2 proteins-interaction-inhibitor dihydrochloride 是p53与MDM2相互作用抑制剂。
-
GC36835
p53 and MDM2 proteins-interaction-inhibitor chiral
2-[4-[[(4S,5R)-4,5-双(4-氯苯基)-2-[4-(1,1-二甲基乙基)-2-乙氧苯基]-4,5-二氢-4,5-二甲基-1H-咪唑-1-基]羰基]-1-哌嗪基]-1-(4-吗啡啉)乙酮
手性p53 and MDM2 proteins-interaction-inhibitor是p53和MDM2相互作用的抑制剂。 - GC36821 OSU-T315 OSU-T315 (ILK-IN-2) is a potent Integrin-Linked Kinase (ILK) inhibitor with IC50 of 0.6 μM. OSU-T315 induces autophagy and apoptosis, both of which are integral to its antiproliferative activity. OSU-T315 exhibits anti-tumor activity.
-
GC36785
NVP-CGM097 sulfate
CGM097 sulfate
An inhibitor of the MDM2-p53 interaction - GC36773 Nrf2-IN-1 Nrf2-IN-1 (Compound 4f) 是 Nrf2 的抑制剂,具有作为治疗急性髓性白血病 (AML) 药物的前景。
- GC36768 NP-12 (TFA) NP-12 (TFA) 是 PD-1 信号通路的一种多肽拮抗剂,在抑制淋巴细胞增殖和效应功能方面对 PD-L1 和 PD-L2 具有等效的拮抗作用。NP-12 (TFA) 具有免疫激活作用、良好的抗肿瘤活性,具有治疗免疫相关不良事件 (irAEs) 的潜力。
-
GC36767
NP-12
NP-12
A PL-1/PD-L interaction inhibitor -
GC36747
Nitroaspirin
2-乙酰氧基苯甲酸-3-硝酸甲基苯酯,NCX 4016
Nitroaspirin (NCX 4016) 是一氧化氮 (NO) 供体和阿司匹林的硝基衍生物,Aspirin 与 Nitroaspirin 联合以抑制环加氧酶。Nitroaspirin (NCX 4016) 具有抗血栓形成和抗血小板特性,并作为 COX-1 的直接和不可逆抑制剂。Nitroaspirin (NCX 4016) 通过下调 EGFR/PI3K/STAT3 信号传导和调节 Bcl-2 家族蛋白,在顺铂耐药人卵巢癌细胞中引起细胞周期停滞和凋亡。 -
GC36743
Nimustine hydrochloride
盐酸尼莫司汀,ACNU
A pyrimidine analog and nitrosourea alkylating agent -
GC36712
Necrostatin 2 S enantiomer
(5S)-5-[(7-氯-1H-吲哚-3-基)甲基]-3-甲基-2,4-咪唑烷二酮
Necrostatin 2 S enantiomer 是 Necrostatin 2 的 S 型异构体。Necrostatin 2 是高活性的坏死性凋亡抑制剂,为有效的 RIPK1 抑制剂,缺乏 IDO 靶向作用。 -
GC36711
Necrostatin 2 racemate
5-[(7-氯-1H-吲哚-3-基)甲基]-3-甲基-2,4-咪唑烷二酮,Necrostatin 1S; Nec-1S; 7-Cl-O-Nec1
A RIPK1 inhibitor - GC36690 Nampt-IN-3 Nampt-IN-3 (Compound 35) 同时抑制烟酰胺磷酸核糖转移酶 (NAMPT) 和 HDAC,IC50 分别为 31 nM 和 55 nM。Nampt-IN-3 有效诱导细胞凋亡 (apoptosis) 和自噬 (autophagy),最终导致细胞死亡。
- GC36652 MPT0B392 MPT0B392 是一种口服活性的喹啉衍生物,作用于 c-Jun N末端激酶 (JNK) 和 apoptosis 的激活剂。MPT0B392 抑制微管蛋白聚合,通过激活 JNK 诱导细胞有丝分裂停滞,线粒体膜电位丧失和 caspases 裂解,最终导致细胞凋亡。MPT0B392 是一种新型微管解聚剂,可增强西罗莫司对耐药急性白血病细胞和多药耐药细胞系的细胞毒性。
- GC36620 MitoTam iodide, hydriodide MitoTam iodide, hydriodide 他莫昔芬衍生物,它是一种电子传递链 (ETC) 抑制剂,抑制衰老细胞中的线粒体膜电位变化并影响线粒体形态。MitoTam iodide, hydriodide 是一种有效的抗癌剂。MitoTam iodide, hydriodide 抑制乳腺癌细胞中呼吸复合物 (CI- respiration) 和超复合物 (SCs) 的形成。MitoTam iodide, hydriodide 可以诱导细胞凋亡 (apoptosis)。
- GC36619 MitoTam bromide, hydrobromide MitoTam bromide, hydrobromide 他莫昔芬衍生物,它是一种电子传递链 (ETC) 抑制剂,抑制衰老细胞中的线粒体膜电位变化并影响线粒体形态。MitoTam bromide, hydrobromide 是一种有效的抗癌剂,可以抑制乳腺癌细胞中呼吸复合物 (CI- respiration) 和超复合物 (SCs) 的形成。MitoTam bromide, hydrobromide 诱导细胞凋亡 (apoptosis)。
-
GC36613
Minodronic acid
1-羟基-2-(咪唑并[1,2-A]吡啶-3-基)乙烷-1,1-双膦酸,YM-529
Minodronic acid (YM529, ONO-5920) is a third-generation nitrogen-cotaining bisphosphonate that is used for the treatment of osteoporosis. Minodronic acid is an aminobisphosphonate that is a selective antagonist of purinergic P2X2/3 receptors involved in pain. -
GC36612
Minnelide
明奈利德
Minnelide 是雷公藤内酯的衍生物,在许多肿瘤类型 (特别是在胰腺癌) 中显示出抗肿瘤 (antitumor) 活性。 Minnelide 可导致凋亡 (apoptotic)。 - GC36605 MI-1061 MI-1061 是一种有效的,口服可生物利用的,化学稳定性的 MDM2 (MDM2-p53 互作) 抑制剂 (IC50=4.4 nM; Ki=0.16 nM)。MI-1061 能有效激活 p53,诱导细胞凋亡,并具有抗肿瘤活性。
- GC36559 Mcl1-IN-9 Mcl1-IN-9 是一种有效的髓细胞白血病基因 1 (Mcl-1) 抑制剂,在重组的 BCR-ABL+ B-ALL 细胞中的 IC50 值为 446 nM,Ki 值为 0.03 nM。